Tarsus Pharmaceuticals, Inc, whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that the U.S. Food and Drug Administration (FDA) approved XDEMVY (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis. XDEMVY, formerly known as TP-03, is the first and only FDA approved treatment to directly target Demodex mites, the root cause of Demodex blepharitis.

The U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has approved, helping increase consumer access to naloxone without a prescription. The timeline for availability and the price of this nonprescription product will be determined by the manufacturer.

Alexion, AstraZeneca Rare Disease, announced that it has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy programmes and enabling technologies from Pfizer Inc. (Pfizer). The agreement furthers Alexion and AstraZeneca’s commitment to advancing next-generation genomic medicines with the addition of complementary pipeline assets and innovative technologies.

Defence Research Laboratory (DRL) has focused its research and development studies on vector-borne diseases, improving the quality of drinking water, waste biodegradation and management, high altitude horticulture and protective cultivation for hilly and border areas, and development of various products for use by defence forces.

The following Research Associate & Junior Research Fellowships are available for candidates possessing requisite qualifications, at DRL Tezpur in the subjects / disciplines as detailed below

JNU’s School of Pharmaceutical Sciences offers cutting-edge pharmacy education programs that help drive innovation and discovery in the industry. The School has established itself as a center of excellence in pharmaceutical education and research and has come to be recognized as the top pharmacy college in Jaipur within only a few years of its establishment. The school has maintained the quality of its programs and the relevancy of its courses by aligning itself with the latest industrial practices.

Under the District Health Society, Vadodara, the posts of the following categories of employees are to be filled on a purely temporary basis for 11 months contract basis and waiting list is being created for the same.

Post : Pharmacist cum Data Assistant

No of posts : 11

Established in 1984, the Institute of Microbial Technology (IMTech) is one among the chain of 37 national laboratories, 6 units and 39 outreach centres of the Council of Scientific and Industrial Research. Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

ADVERTISEMENT FOR WALK IN INTERVIEW FOR RE-EMPLOYMENT OF 21 NO. OF DIFFERENT CATEGORIES OF POST FOR THE OFFICE OF THE SUPERINTENDENT, DHARANIDHAR MEDICAL COLLEGE & HOSPITAL, KEONJHAR ON CONTRACTUAL BASIS BY RE-EMPLOYING RETIRED GOVERNMENT EMPLOYEES FOR DHARANIDHAR MEDICAL COLLEGE & HOSPITAL, KEONJHAR.

Post : Pharmacist

National Forensic Sciences University, the erstwhile Gujarat Forensic Sciences University is the brain child of Govt of Gujarat. It was established by the Hon’ble Prime Minister of India Shri. Narendra Modiji, then Chief Minister of Gujarat in 2009 with a sole objective of creating professional experts in the field of Forensic sciences. At a juncture of spiking number of crimes involving sophisticated technologies and much evolved modus operandi, there was a need for scientists and technocrats.

Established in 1984, the Institute of Microbial Technology (IMTech) is one among the chain of 37 national laboratories, 6 units and 39 outreach centres of the Council of Scientific and Industrial Research. Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

Guru Nanak Dev University was established at Amritsar on November 24, 1969 to mark the 500th birth anniversary of Sri Guru Nanak Dev Ji. It is both a residential and an affiliating university. In conceiving the future course of the University, the objectives enshrined in the Guru Nanak Dev University Act 1969, emphasised that the new University would make provision for imparting education and promoting research in the humanities, learned professions, sciences, especially of applied nature and technology.

The Laboratory was established in 1941 as a research and production centre, known as Drug Research Laboratory of J&K State and was later taken over by Council of Scientific & Industrial Research (CSIR) of Govt. of India in December 1957 as Regional Research Laboratory, Jammu. In view of its core strength in natural products based drug discovery, the mandate of Institute was redefined in 2005 and its name changed to Indian Institute of Integrative Medicine (IIIM).

Macleods Pharmaceuticals, fastest growing company was established in 1986. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140 plus countries. Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities.

Post : Sr. Officer / Officer

AnaCipher Clinical Research Organization, a division of Indoco Remedies Ltd. is a Contract Research Organization specialized in bioequivalence and analytical studies. The state-of-the-art facility is spread over an area of 40,000 sq. ft. at Hyderabad, India, with capabilities to conduct bioavailability and bioequivalence studies, bioanalytical method development and validation, sample processing and analysis, statistical analysis and reporting.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally. With a presence in over 70 countries, Emcure's goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

Post : DGM / GM / SR.GM

Department : Formulation Development, NDDS (Injectable)

University of Utah Health researchers have discovered that Metformin, a common drug that’s been used in diabetes treatment for more than half a century, has surprising applications on a cellular level. It can target “zombie-like cells,” called senescent cells, which impact muscle function. Senescent cells secrete factors associated with inflammation that may underlie fibrotic tissue, a hardening or scarring of tissues. Metformin also reduces muscle atrophy. Their findings published in Aging Cell.

Scientists have unraveled the step-by-step activation process of a protein with a deep evolutionary history in all domains of life, opening the door to harnessing its functions for use as a biotechnology tool.

The protein belongs to the “superfamily” of Argonaute proteins, which previous research has suggested to be involved in gene silencing, a fundamental process known as RNA interference.

Asprius Lifesciences has announced that it has developed treatment for Diabetic Neuropathy, a condition that results in nerve damage in peripheral areas of the body. The company said it has already filed a patent for the Fixed-Dose Combination that holds promise in treating peripheral neuropathy.